Drug intelligence / Profile preview

modified triple antibiotic paste

Development stage
Phase 4
Lead developer
Tanta University
Modality
Small Molecules
Administration
Topical
01

Overview

Modified triple antibiotic paste (MTAP) is a combination antimicrobial formulation used as an intracanal medicament in endodontic therapy, specifically for treating secondary endodontic infections and in regenerative procedures. Developed and evaluated by researchers at Tanta University, this specific formulation is modified typically by replacing minocycline with another antibiotic (such as clindamycin or cefaclor) to prevent the tooth discoloration associated with traditional triple antibiotic paste (TAP). The paste typically contains metronidazole, ciprofloxacin, and a third antibiotic, which work synergistically to eradicate persistent intracanal pathogens, most notably *Enterococcus faecalis*. Metronidazole provides activity against anaerobic bacteria, ciprofloxacin offers broad-spectrum gram-negative coverage, and the third agent targets gram-positive organisms.

Other names
MTAPmodified triple antibiotic paste-Tanta University
02

Targets

Bacterial RibosomeBacterial 50S ribosomal subunitNeuraminidaseDNA gyraseTopo IV (Bacterial Topoisomerase IV)PBP (Penicillin-binding protein family)DNA

Beyond the preview

Go deeper on modified triple antibiotic paste.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on modified triple antibiotic paste.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call